Penny stocks can be incredibly exciting if you know how to trade them. On a given day, we’ll see at least a handful of cheap stocks go up hundreds of percentage points thanks to some random catalyst. While the moves may not last more than a few hours or several days, the point is that people make money through them. Feast. So, where do you look to find names for your watch list? Today we’ll take a closer look at a few hot stock insiders who decided to buy this year.
Benny Stokes TL; 30-second summary of the doctor
- Penny stocks can be worth the bonus if you know how to trade them.
- Insider trading is something retail investors look for in order to gauge sentiment.
- If management buys or sells shares, that will not automatically be a reason to do the same. However it could have an impact on market sentiment.
- Today we look at a little penny stock to buy According to insiders now.
The important thing to remember about (legal) insider trading is that it is not an instant signal to copy trades. Some insiders buy or sell based on predetermined investment plans. In the meantime, other insiders may buy “big positions” based on one person’s opinion, but in the grand scheme of things, that may not matter to the insiders, personally. Either way, when insiders start making moves, market sentiment tends to follow. Today we look at a bunch of Insiders buy penny stocks in 2022.
buy penny stock [according to insiders]
- Oragenics Inc. (NYSE: OGEN)
- Flotek Industries Inc. (NYSE: FTK)
- Vital Therapies (NASDAQ: BRTX)
- ClearOne (NASDAQ: CLRO)
1. Oragenics Inc. (NYSE: OGEN)
Oragenics stock started the new year in style with a big move to $0.56. This followed a year-end sell-off that sent cash stocks back to their lowest levels in the 40-cent range. The biotech company reported that it has extended a licensing deal with Canada’s National Research Council to develop an intranasal vaccine for the omicron variant. The company explained that the board’s techniques will help speed up the evaluation process for the candidate in preclinical and clinical studies.
The company recently announced the results of a study evaluating the immunity and effect of reducing the viral load of a SARS-CoV-2 vaccine candidate in a challenging study. This provided preclinical data for both intramuscularly administered formulations. Frederick W. Tling, Ph.D., CEO of Oragenics, explained in a December public report, “…we plan to focus on the intranasal delivery route of Terra CoV-2 due to the relative lack of competition and the expected advantages from intranasal delivery of the vaccine…will be Findings from this second preclinical study are part of our investigation file for new drugs to the US Food and Drug Administration, expected in the second quarter of 2022.”
Read: 3 Short squeezes of Penny stocks to buy under $5 right now
With more potential near-term catalysts to look for, OGEN stock gained some early attention. Additionally, insiders are picking up stocks at these lower levels. Director Robert Kosky filed a Form 4 this month showing a recent purchase of 1 million shares of OGEN stock. The shares were purchased at average prices between $0.4498 and $0.474.
See all OGEN stock filings here
2. Flotek Industries Inc. (NYSE: FTK)
Flotek has been on our radar ever since the company announced an unsolicited purchase last year. Details are still murky. However, the company brought in a consulting firm to help. Flotek has received an offer for a possible transaction of all or part of the company before New Year’s Eve 2021.
With the move towards ESG initiatives in 2021 and 2022, FTK stock is gaining some attention. Its model is based on minimizing the environmental impact of energy on different ecosystems. Through its chemistry, the company provides cleaning and sanitizing products. Flotek also provides real-time data analytics for customers in the energy industry to analyze ESG operations.
This year, insider purchases have already begun. CEO John Gibson Jr. bought a few thousand shares of FTK on the last day of 2021. This was reported on January 4th and appears to have become a focal point for some stock market traders today. While we await more details about this proposed transaction, speculative momentum remains a driving force.
See all FTK stock filings here
3. Vital Therapies (NASDAQ: BRTX)
BioRestorative is still licking its wounds as of 2021, but some in-house activities may have addressed that problem a bit for now. The company did a reverse split and a bullish simultaneous listing with the Nasdaq in the last quarter. The stocks ended up hitting highs of around $15 but have since fallen back below the cash-equity threshold.
The initial public offering of the company and the funds raised with it were conducted to consolidate and financially strengthen its position in intellectual property. BioRestorative builds a suite of cell and tissue protocols that include adult stem cells. Its two primary programs relate to lumbosacral disc disorders and metabolic disorders, including obesity visiting BRTX-100 and ThermoStem pads respectively.
Read: Penny Energy Stocks Soaring Today, Here Are 3 Things To Watch For And Why
The recent grant to use the BRTX-100 valuation has brought more optimism to the market. Ahead of HC Wainwright BioConnect’s January conference presentations, insiders also began buying shares. Earlier this week, CEO Lance Alstadt bought a few thousand shares of BRTX at an average price of $3.85. This brings his total direct holdings to more than 161,000 shares.
See all BRTX stock filings here
4. ClearOne (NASDAQ: CLRO)
Like BioRestorative, ClearOne made unsuccessful attempts to regain what it lost in late 2021. Initially, the company came under fire after selling pressure drove the stock price down in October. CLRO’s stock fell from over $2 to under $1.50 when all was said and done. The loss of earnings in the third quarter results added to selling pressure.
Fast forward a bit, and ClearOne has engaged the likes of DISH Network and Rochester Institute of Technology in Dubai. ClearOne was recently awarded US patents #11,190,378 “Transmission of Information Signals on a Differential Signal Pair” and #1,188,133 “A system for transmitting power to a remote PoE subsystem by forwarding the PD input voltage.”
This week, the company also announced the launch of the DIALOG® 10 USB. According to the company, this is “the industry’s only single-channel wireless microphone system that delivers professional-quality audio with USB connectivity.”
As the world remains in limbo from the lasting impact of the virus, hypothetical solutions are essential. ClearOne specializes in conference and broadcast solutions, and after the launch of the DIALOG 10, it looks like insiders may be optimistic about 2022. This week, Edward Bagley, owner of ClearOne with 10%, announced the purchase of more than 1.5 million shares of CLRO stock at an average of Price $1.30. This brings his total holdings to more than 10 million shares.
See all CLRO stock filings here
Final Thoughts on Insider Trading
When it comes to (legal) insider trading, people like to follow the money. It can spark emotions in the stock market and give reassurance or fear depending on the trades made. It is important to remember that no matter what management may do, you are the one who pulls the trigger. Make sure to do a lot of research before deciding whether or not to enter into any trade or insider trading.
If you enjoyed this article and are interested in learning how to trade so that you have the best chance of earning consistently, then you need to check out this YouTube channel. Click here now!